Product Pathways - Apoptosis
Cleaved Caspase-3 (Asp175) Blocking Peptide #1050
|1050S||100 µg||---||In Stock||---|
|1050||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
This peptide is used to block Cleaved Caspase-3 (Asp175) Antibody #9661 and #9664 reactivity.
The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. The peptide blocks Cleaved Caspase-3 (Asp175) Antibody #9661 by immunohistochemistry and Western Blotting.
Western blot analysis of cell extracts from Jurkat cells treated with 0.25 mg/ml cytochrome c, using Cleaved Caspase-3 (Asp175) Antibody #9661 without (left) and with (right) preincubation with cleavage-peptide.
Directions For Use
Use as a blocking reagent to evaluate the specificity of antibody reactivity in immunohistochemistry and Western blot protocols. For immunohistochemistry, add twice the volume of peptide as volume of antibody used in 100 µl total volume. Incubate for a minimum of 30 minutes prior to adding the entire volume to the slide. Recommended antibody dilutions can be found on the relevant product data sheet.
For Western immunoblotting, add 10 µl of antibody and 10 µl of blocking peptide to 10 ml of antibody dilution buffer, and incubate at room
temperature for 30 minutes before allowing to react with the blot.
Caspase-3 (CPP-32, Apoptain, Yama, SCA-1) is a critical executioner of apoptosis, as it is either partially or totally responsible for the proteolytic cleavage of many key proteins, such as the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (1). Activation of caspase-3 requires proteolytic processing of its inactive zymogen into activated p17 and p12 fragments. Cleavage of caspase-3 requires the aspartic acid residue at the P1 position (2).
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.